RESUMEN
BACKGROUND: Immunosuppressive (IS) therapy is indicated to treat progressive sarcoidosis, but randomized controlled trials to guide physicians in the use of steroid sparing agents are lacking. The aim of this retrospective study was to examine the role of mycophenolate mofetil (MMF) as an alternative therapy in the treatment of sarcoidosis. METHODS: A retrospective chart review of all patients who had been prescribed MMF between January 2008 and October 2011 was conducted. Patients with insufficient data or who had another IS therapy initiated concomitantly with MMF, including prednisone, were excluded. Physiological data obtained at the time MMF therapy was initiated as well as six and twelve months before and after therapy was extracted. Longitudinal analyses of the effect of MMF on changes in pulmonary function at MMF start, 6 months, 12 months pre and post MMF therapy were conducted. RESULTS: 37/76 patients met our inclusion/exclusion criteria. There were no statistically significant changes in PFT measurements pre and post MMF therapy. We did find a trend (p = 0.07) towards improvement in DLCO 12 months pre and post MMF in patients who were started on MMF due to intolerance to previous IS therapy compared to those who were unresponsive to their previous IS therapy. We also noted a reduction in prednisone dose in those treated with MMF. CONCLUSION: MMF appears to offer no extra benefit to sarcoidosis patients unresponsive to previous steroid-sparing agents, but may be beneficial in patients intolerant to their previous steroid-sparing agent. Additional studies investigating the efficacy of MMF as the initial steroid-sparing agent are needed to further clarify the role of MMF in sarcoidosis.
Asunto(s)
Inmunosupresores/uso terapéutico , Ácido Micofenólico/análogos & derivados , Sarcoidosis Pulmonar/tratamiento farmacológico , Adulto , Anciano , Esquema de Medicación , Evaluación de Medicamentos/métodos , Quimioterapia Combinada , Femenino , Glucocorticoides/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Ácido Micofenólico/uso terapéutico , Prednisona/administración & dosificación , Capacidad de Difusión Pulmonar/efectos de los fármacos , Estudios Retrospectivos , Sarcoidosis Pulmonar/fisiopatología , Resultado del Tratamiento , Capacidad Vital/efectos de los fármacosRESUMEN
BACKGROUND: Among asbestos-exposed individuals, abnormal spirometry is usually associated with parenchymal abnormalities or diffuse pleural thickening. Localised pleural thickening (LPT), the most common abnormality associated with asbestos exposure, is typically thought to be a marker of exposure with little clinical consequence. Our objective was to determine if abnormal spirometry is associated with LPT independent of other abnormalities, using data from community-based screening conducted in Libby, Montana. METHODS: Subjects were a subset of screening participants comprising persons with interpretable spirometry and chest radiograph results (n=6475). Chest radiographs were independently evaluated by two or three B readers, and participants were classified by mutually exclusive categories of spirometry outcome: normal, restriction, obstruction or mixed defect. RESULTS: Restrictive spirometry was strongly associated with parenchymal abnormalities (OR 2.9; 95% CI 1.4 to 6.0) and diffuse pleural thickening (OR 4.1; 95% CI 2.1 to 7.8). Controlling for the presence of these abnormalities as well as age, smoking status and other covariates, restrictive spirometry was also associated with LPT (OR 1.4; 95% CI 1.1 to 1.8). The risk of restrictive spirometric findings correlated with the severity of LPT. CONCLUSIONS: In this large community-based screening cohort, restrictive spirometry is significantly associated with LPT, indicating that this abnormality may result in lung function impairment. Physicians treating patients exposed to Libby amphibole should be aware that LPT may have functional consequences.
Asunto(s)
Asbestos Anfíboles/toxicidad , Asbestosis/diagnóstico por imagen , Asbestosis/fisiopatología , Enfermedades Pleurales/diagnóstico por imagen , Enfermedades Pleurales/fisiopatología , Espirometría , Adolescente , Adulto , Estudios de Cohortes , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Enfermedades Pleurales/etiología , Valor Predictivo de las Pruebas , Radiografía , Adulto JovenAsunto(s)
Amianto/toxicidad , Enfermedades Profesionales/inducido químicamente , Exposición Profesional/efectos adversos , Enfermedades Pleurales/inducido químicamente , Enfermedades Torácicas/inducido químicamente , Humanos , Minería , Enfermedades Profesionales/diagnóstico por imagen , Enfermedades Pleurales/diagnóstico por imagen , Radiografía Torácica , Enfermedades Torácicas/diagnóstico por imagenRESUMEN
Beryllium (Be)-antigen presentation to Be-specific CD4(+) T cells from the lungs of patients with chronic beryllium disease (CBD) results in T cell proliferation and TNF-alpha secretion. We tested the hypothesis that Be-induced, CBD bronchoalveolar lavage (BAL) T cell, transcription-dependent, TNF-alpha secretion was accompanied by specific transcription factor upregulation. After 6 h of Be stimulation, CBD BAL cells produced a median of 883 pg/ml TNF-alpha (range, 608-1,275 pg/ml) versus 198 pg/ml (range, 116-245 pg/ml) by unstimulated cells. After 12 h CBD BAL cells produced a median of 2,963 pg/ml (range, 99-9,424 pg/ml) TNF-alpha versus 55 pg/ml (range, 0-454) by unstimulated cells. Using real-time RT-PCR, Be-stimulated TNF-alpha production at 6 h was preceded by a 5-fold increase in TNF-alpha pre-mRNA copy number:beta-actin copy number (Be median ratio 0.21; unstimulated median ratio 0.04). The median ratio of mature TNF-alpha mRNA:beta-actin mRNA was upregulated 1.4-fold (Be median ratio 0.17; unstimulated median ratio 0.12). Be exposure in the presence of the transcription inhibitor pentoxifylline (PTX) decreased CBD BAL cell TNF-alpha pre-mRNA levels > 60%, whereas treatment with the mRNA splicing inhibitor 2-aminopurine (2AP) decreased levels 40% relative to Be exposure alone. PTX treatment decreased mature TNF-alpha mRNA levels 50% while 2AP decreased levels > 80%, relative to Be exposure alone. Beryllium exposure specifically upregulated transcription factors AP-1 and NF-kappaB. The data suggest that Be exposure induces transcription-dependent TNF-alpha production, potentially due to upregulation of specific transcription factors.
Asunto(s)
Beriliosis/genética , Berilio/farmacología , Transcripción Genética/efectos de los fármacos , Factor de Necrosis Tumoral alfa/biosíntesis , Factor de Necrosis Tumoral alfa/genética , Adulto , Líquido del Lavado Bronquioalveolar/citología , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Separación Celular , Femenino , Dosificación de Gen , Humanos , Cinética , Lipopolisacáridos/farmacología , Masculino , Persona de Mediana Edad , FN-kappa B/metabolismo , Proteínas Nucleares/metabolismo , Precursores del ARN/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Factor de Transcripción AP-1/metabolismo , Factores de Transcripción/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/genéticaRESUMEN
BACKGROUND: Sputum samples for lung cancer screening trials are typically collected at home into specimen containers prefilled with cytologic fixative. Collection, transit, and storage expose samples to environmental conditions that may introduce artifacts that could confound evaluation. We examined whether the type of cytological fixative and exposure to different environmental conditions introduces artifacts that affect cytological analysis. METHODS: Sputum fixed in Saccomanno fluid (SAC), containing methyl, ethyl, and propyl alcohols and polyethylene glycol, or CytoRich Red solution (CRR), containing methyl and isopropyl alcohols and ethylene glycol, plus formaldehyde, was aliquoted and exposed for 8 h to the following conditions: (a) -20 degrees C freezer, (b) 60 degrees C oven, (3) direct sunlight, and (4) room temperature. Cell morphometry was evaluated using computer-assisted image analysis (CAIA). RESULTS: The values obtained for CAIA analysis of sputum were affected by the type of fixative used. Temperature extremes and sunlight dramatically altered nuclear morphometry of SAC-fixed cells. Artifacts were not observed in CRR-fixed cells. CONCLUSIONS: The effects of environmental exposures were minimized if sputum was placed in a formalin-containing fixative such as CRR. If an alcohol-based fixative such as SAC is used, sample handling, transport, and storage must be monitored to prevent the introduction of artifacts.
Asunto(s)
Núcleo Celular/ultraestructura , Ambiente , Células Epiteliales/citología , Fijadores , Manejo de Especímenes/métodos , Esputo/citología , Forma de la Célula , Humanos , Procesamiento de Imagen Asistido por Computador , Luz , Neoplasias Pulmonares/diagnóstico , TemperaturaRESUMEN
Despite interest in the use of nuclear morphometry for cancer diagnosis and prognosis as well as to monitor changes in cancer risk, no generally accepted statistical method has emerged for the analysis of these data. To evaluate different statistical approaches, Feulgen-stained nuclei from a human lung epithelial cell line, BEAS-2B, and a human lung adenocarcinoma (non-small cell) cancer cell line, NCI-H522, were subjected to morphometric analysis using a CAS-200 imaging system. The morphometric characteristics of these two cell lines differed significantly. Therefore, we proceeded to address the question of which statistical approach was most effective in classifying individual cells into the cell lines from which they were derived. The statistical techniques evaluated ranged from simple, traditional, parametric approaches to newer machine learning techniques. The multivariate techniques were compared based on a systematic cross-validation approach using 10 fixed partitions of the data to compute the misclassification rate for each method. For comparisons across cell lines at the level of each morphometric feature, we found little to distinguish nonparametric from parametric approaches. Among the linear models applied, logistic regression had the highest percentage of correct classifications; among the nonlinear and nonparametric methods applied, the Classification and Regression Trees model provided the highest percentage of correct classifications. Classification and Regression Trees has appealing characteristics: there are no assumptions about the distribution of the variables to be used, there is no need to specify which interactions to test, and there is no difficulty in handling complex, high-dimensional data sets containing mixed data types.
Asunto(s)
Adenocarcinoma/patología , Carcinoma de Pulmón de Células no Pequeñas/patología , Interpretación Estadística de Datos , Diagnóstico por Computador/estadística & datos numéricos , Células Epiteliales/patología , Neoplasias Pulmonares/patología , Modelos Estadísticos , Adenocarcinoma/clasificación , Bronquios/patología , Carcinoma de Pulmón de Células no Pequeñas/clasificación , Técnicas de Cultivo de Célula , Núcleo Celular/patología , Células Epiteliales/clasificación , Humanos , Neoplasias Pulmonares/clasificación , Redes Neurales de la Computación , Sensibilidad y Especificidad , Estadísticas no Paramétricas , Células Tumorales CultivadasRESUMEN
Beryllium (Be) presentation to CD4+ T cells from patients with chronic beryllium disease (CBD) results in T cell activation, and these Be-specific CD4+ T cells undergo clonal proliferation and T-helper 1-type cytokine production. In exposed workers, genetic susceptibility to this granulomatous disorder is associated with particular HLA-DPB1 alleles. We hypothesized that these HLA-DP molecules could mediate Be-stimulated tumor necrosis factor-alpha (TNF-alpha) messenger RNA (mRNA) and protein production. Using intracellular cytokine staining, we found that treatment with an anti-HLA-DP, but not anti-HLA-DR, monoclonal antibody inhibited Be-stimulated TNF-alpha expression in lung CD3+ CD4+ T cells. This monoclonal antibody also blocked Be-specific T cell proliferation, increased production of TNF-alpha mature-mRNA transcripts, and increased TNF-alpha protein production by Be-stimulated CBD peripheral blood mononuclear cells and bronchoalveolar lavage (BAL) cells. The Be-stimulated upregulation of TNF-alpha mature-mRNA levels with TNF-alpha protein production was a unique property of CBD BAL cells, and did not occur in BAL cells from Be-sensitized patients without CBD, or sarcoidosis BAL cells. This study identifies HLA-DP as a regulatory component in the activation of T cell receptors on Be-specific CD4+ T cells from CBD patients resulting in proliferation and proinflammatory cytokine production.
Asunto(s)
Beriliosis/inmunología , Berilio/efectos adversos , Linfocitos T CD4-Positivos/metabolismo , Antígenos HLA-DP/inmunología , Antígenos HLA-DP/metabolismo , Factor de Necrosis Tumoral alfa/biosíntesis , Anticuerpos Monoclonales/farmacología , Beriliosis/metabolismo , Beriliosis/fisiopatología , Líquido del Lavado Bronquioalveolar/citología , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , División Celular/efectos de los fármacos , División Celular/inmunología , Citocinas/genética , Citocinas/inmunología , Citocinas/metabolismo , Femenino , Antígenos HLA-DP/efectos de los fármacos , Humanos , Mediadores de Inflamación/metabolismo , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/inmunología , Activación de Linfocitos/efectos de los fármacos , Activación de Linfocitos/inmunología , Masculino , Persona de Mediana Edad , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Receptores de Antígenos de Linfocitos T/efectos de los fármacos , Receptores de Antígenos de Linfocitos T/inmunología , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/genética , Regulación hacia Arriba/inmunologíaRESUMEN
Lung cancer is the most common thoracic malignancy caused by exposures at work and in the environment. The most unique thoracic malignancy is mesothelioma, because it is relatively rare and one of only a few neoplasms for which one specific inciting agent-asbestos-has been identified. Based on epidemiologic studies, approximately 15% of lung cancers in men and 5% of lung cancers in women are caused by occupational exposures. The International Agency for Research on Cancer has devised a rating system by which, based on animal and human data, they assign an agent, mixture, or exposure circumstance to one of five categories, ranging from group 1 (agent is carcinogenic to humans) to group 4 (agent is probably not carcinogenic to humans). Group 1 pulmonary carcinogens reviewed in this article include arsenic, asbestos, beryllium, bis (chloromethyl) ether, cadmium, chromium (IV), mustard gas, nickel, radon, and silica. The clinical presentation and pathology of lung cancers and mesothelioma caused by such exposures do not differ from those of cancers caused by other factors. The key to the recognition of a thoracic malignancy caused by workplace or environmental exposures is clinical suspicion and consideration of all causes for the disease present. Recognition of an exposure-related case of lung cancer or mesothelioma can aid in the identification of excess risk for a whole workforce or community and can lead to actions to reduce exposure, thus preventing future cases. In addition, such recognition allows the individuals struck by devastating illness to exercise their legal rights to compensation if so desired.